Second Sight Medical Products (Second Sight Medical Products) Current Deferred Taxes Liabilities : $0.00 Mil (As of Jun. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Second Sight Medical Products Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Second Sight Medical Products's current deferred tax liabilities for the quarter that ended in Jun. 2022 was $0.00 Mil.

Second Sight Medical Products Current Deferred Taxes Liabilities Historical Data

The historical data trend for Second Sight Medical Products's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Current Deferred Taxes Liabilities Chart

Second Sight Medical Products Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Second Sight Medical Products Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Second Sight Medical Products Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Second Sight Medical Products (Second Sight Medical Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYES) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

13170 Telfair Avenue, Sylmar, CA, USA, 91342

Website

https://www.secondsight.com

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Executives

Lisa Ellen Porter	officer: Chief Medical Officer	778 CORDILLERAS AVE, SAN CARLOS CA 94070
Donald Dwyer	officer: Chief Business Officer	54 CHERRY FARM LANE, WEST CHESTER PA 19382
Truc Le	officer: COO	1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn	director, officer: CEO	C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Brigid Makes	officer: CFO	20245 SW 95TH AVENUE, TUALATIN OR 97062
Gregg Williams	director, 10 percent owner	PO BOX 200, WALLED LAKE MI 48390-0200
Wilford Dean Baker	director	200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p.	director	3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar	officer: Acting CEO	13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo	officer: Controller	4485 FORESTGLEN CT, MOORPARK CA 93021
Jonathan Will Mcguire	director, officer: Chief Executive Officer	96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Jessy Dana Dorn	officer: VP-Clin & Scientific Affairs	12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Edward David Randolph	officer: Vice President Manufacturing	12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR CA 91342
Matthew J Pfeffer	director
Aaron Mendelsohn	director	224 15TH STREET, SANTA MONICA CA 90402